NCT07097363
- Conditions
- B-Cell Non-Hodgkin Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +23 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Transformed B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma to Diffuse Large B-Ce
Explore clinical trials studying Transformed B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma to Diffuse Large B-Ce. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study
Transformed B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma to Diffuse Large B-Ce trial results
Related conditions
- B-Cell Non-Hodgkin Lymphoma (1)
- Burkitt Lymphoma (1)
- Diffuse Large B-Cell Lymphoma, Not Otherwise Specified (1)
- DNA Virus Infections (1)
- EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified (1)
- Epstein-Barr Virus Infections (1)
- Hemic and Lymphatic Diseases (1)
- Herpesviridae Infections (1)